A showcase study on personalized in silico drug response prediction based on the genetic landscape of muscle invasive bladder cancer

Improved and cheaper molecular diagnostics allow the shift from “one size fits all” therapies to personalised treatments targeting the individual tumor. However, the wealth of potential targets based on comprehensive sequencing remains a yet unsolved challenge that prevents its routine use in clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Krentel, Friedemann, Singer, Franziska, Rosano-Gonzalez, María Lourdes, Gibb, Ewan A., Liu, Yang, Davicioni, Elai, Keller, Nicola, Stekhoven, Daniel J., Kruithof-de Julio, Marianna, Seiler, Roland
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955125/
https://www.ncbi.nlm.nih.gov/pubmed/33712636
http://dx.doi.org/10.1038/s41598-021-85151-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955125/
https://www.ncbi.nlm.nih.gov/pubmed/33712636
http://dx.doi.org/10.1038/s41598-021-85151-3

Ejemplares similares